Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.19
-0.08 (-3.31%)
At close: Jun 23, 2025, 3:59 PM
2.16
-1.14%
After-hours: Jun 23, 2025, 05:35 PM EDT
-3.31% (1D)
Bid | 2.16 |
Market Cap | 10.48M |
Revenue (ttm) | n/a |
Net Income (ttm) | -6.76M |
EPS (ttm) | -9.02 |
PE Ratio (ttm) | -0.24 |
Forward PE | -2.84 |
Analyst | Buy |
Ask | 2.36 |
Volume | 112,292 |
Avg. Volume (20D) | 3,327,046 |
Open | 2.22 |
Previous Close | 2.27 |
Day's Range | 2.16 - 2.24 |
52-Week Range | 0.97 - 9.79 |
Beta | 0.85 |
About PHIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+17.14%
Phio Pharmaceuticals shares are trading higher HC ...
Unlock content with
Pro Subscription
1 month ago
+18.6%
Phio Pharmaceuticals shares are trading higher after the company announced pathology results from the third cohort in its INTASYL PH-762 skin cancer clinical trial.